Celrà, Spain

Eugènia Pagans Lista

This inventor holds 1 USPTO granted patent. Top assignee: Medichem, S.a.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugènia Pagans Lista. Retrieved from https://idiyas.com/inventor/eugandegravenia-pagans-lista

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eugènia Pagans Lista: Innovator in Pharmaceutical Processes

Introduction

Eugènia Pagans Lista is a notable inventor based in Celrà, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the production of gabapentin, a medication used to treat various conditions.

Latest Patents

Eugènia holds a patent for a process for producing pharmaceutical grade gabapentin. This invention describes a method that involves neutralizing an alcoholic solution of gabapentin hydrochloride with basic ion exchange resins. The process allows for the direct isolation of gabapentin without the need for forming or isolating intermediates, streamlining production and enhancing efficiency.

Career Highlights

Eugènia is associated with Medichem, S.A., a company known for its focus on pharmaceutical development and production. His work has contributed to advancements in the manufacturing processes of essential medications.

Collaborations

Eugènia has collaborated with notable colleagues, including Jordi Bosch Lladó and Mà Del Carmen Onrubia Miguel. These partnerships have fostered innovation and development within the pharmaceutical sector.

Conclusion

Eugènia Pagans Lista's contributions to the pharmaceutical industry, particularly through his patented process for gabapentin production, highlight his role as an innovator. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…